Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
(Posted Apr 21, 2024 8AM)
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants
(Posted Apr 21, 2024 8AM)
Clinical Application of Different Liquid Biopsy Components in Hepatocellular Carcinoma
J Xu et al, JPM, April 15, 2024 (Posted Apr 15, 2024 2PM)
Nucleic acid-based drugs for patients with solid tumours.
Sebastian G Huayamares et al. Nat Rev Clin Oncol 2024 4 (Posted Apr 10, 2024 8AM)
Jin Ju Kim et al. Clin Lab 2024 70(4)
Assessing the value of incorporating a polygenic risk score with non-genetic factors for predicting breast cancer diagnosis in the UK Biobank.
Jennifer A Collister et al. Cancer Epidemiol Biomarkers Prev 2024
Correlation between NGS panel-based mutation results and clinical information in colorectal cancer patients.
Bo Cheng et al. Heliyon 2024 10(7) e29299
Cost-effectiveness of BRCA1 testing at time of obstetrical prenatal carrier screening for cancer prevention.
Shayan M Dioun et al. Am J Obstet Gynecol 2024
Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.
Isabelle Bedrosian et al. J Clin Oncol 2024 42(5) 584-604
Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries.
Riccardo Oliva et al. Int J Gynecol Cancer 2024
Postpartum Breast Cancer and Survival in Women With Germline BRCA Pathogenic Variants.
Zhenzhen Zhang et al. JAMA Netw Open 2024 7(4) e247421
Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer.
Sara Torres-Esquius et al. JAMA Netw Open 2024 7(4) e247811
Uptake of Risk-Reducing Measures, Cascade Testing, and Related Challenges Among Carriers of Breast Cancer-Associated Germline Pathogenic Variants in Mexico.
Fernanda Mesa-Chavez et al. JCO Glob Oncol 2024 10e2300417
A Machine Learning Algorithm Facilitates Prognosis Prediction and Treatment Selection for Barcelona Clinic Liver Cancer Stage C Hepatocellular Carcinoma.
Ji Won Han et al. Clin Cancer Res 2024
More
About Cancer PHGKB
Cancer PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to cancer...more
Content Summary
- CDC Information (133)
- NIH Information (399)
- COVID-19 (1112)
- CDC Genomics and Precision Health Publications (320)
- Human Genome Epidemiologic Studies (60542)
- GWAS Studies (912)
- Tier-Classified Guidelines (214)
- Genomics Precision Health (14912)
- Non-Genomics Precision Health (2249)
- Pathogen Advanced Molecular Detection (156)
Common Type
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 25, 2024
- Content source: